Araújo YB, Almeida ABR, Viana MFM, Meneguz-Moreno RA. Use of atherogenic indices as assessment methods of clinical atherosclerotic diseases. Arquivos Brasileiros De Cardiologia. 2023;120:e20230418.
Manent JIR, Gil PT, Villalonga JLC, Lliteras PM, González ÁAL, Oliveira HJP. Relationship between atherogenic dyslipidemia and lipid triad with scales that assess Non alcoholic liver disease in 418,343 Spanish workers. Acad J Health Sciences: Med Balear. 2023;38:66–73.
Olamoyegun MA, Oluyombo R, Asaolu SO. Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria. Ann Afr Med. 2016;15:194–9.
Edwards MK, Loprinzi PD. Physical activity and diet on atherogenic index of plasma among adults in the united states: mediation considerations by central adiposity. Eur J Clin Nutr. 2018;72:826–31.
Chairistanidou C, Karatzi K, Karaglani E, Usheva N, Liatis S, Chakarova N, Mateo-Gallego R, Lamiquiz-Moneo I, Radó S, Antal E. Diet quality in association to lipidaemic profile in adults of families at high-risk for type 2 diabetes in europe: the Feel4Diabetes study. Nutr Metabolism Cardiovasc Dis. 2022;32:1175–85.
Alemam H, Mustafa A, Shebani A, Attayeb M, Akarem A, Elzagheid A, Eltaib F. Assessment of Atherogenic Risk indices and Dyslipidemia in Libyan Smokers. 2024.
Maia I, Oliveira A, Santos AC. Food insecurity is associated with an unhealthy lifestyle score in middle-and older-aged adults: findings from the EPIPorto cohort. Food Secur. 2023;15:661–71.
Vajdi M, Karimi A, Farhangi MA, Ardekani AM. The association between healthy lifestyle score and risk of metabolic syndrome in Iranian adults: a cross-sectional study. BMC Endocr Disorders. 2023;23:16.
Baechle C, Lang A, Strassburger K, Kuss O, Burkart V, Szendroedi J, Müssig K, Weber KS, Schrauwen-Hinderling V, Herder C. Association of a lifestyle score with cardiometabolic markers among individuals with diabetes: a cross-sectional study. BMJ Open Diabetes Res Care. 2023;11:e003469.
Sarrafzadegan N, Hassannejad R, Roohafza H, Sadeghi M, Talaei M, Oveisgharan S, Mansourian M. A 10-year Isfahan cohort on cardiovascular disease as a master plan for a multi-generation non-communicable disease longitudinal study: methodology and challenges. J Hum Hypertens. 2019;33:807–16.
Roohafza H, Feizi A, Gharipour M, Khani A, Dianatkhah M, Sarrafzadegan N, Sadeghi M. Development and validation of a socioeconomic status short-form questionnaire (SES-SQ). ARYA Atheroscler. 2021;17:1–9.
Hagströmer M, Oja P, Sjöström M. The international physical activity questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr. 2006;9:755–62.
Farhadnejad H, Teymoori F, Asghari G, Mokhtari E, Mirmiran P, Azizi F. The higher adherence to a healthy lifestyle score is associated with a decreased risk of type 2 diabetes in Iranian adults. BMC Endocr Disorders. 2022;22:42.
Mohammadifard N, Haghighatdust F, Kelishadi R, Bahonar A, Dianatkhah M, Heidari H, Maghroun M, Dehghan M. Validity and reproducibility of a semi-quantitative food frequency questionnaire for Iranian adults. Nutr Dietetics. 2021;78:305–14.
Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M, Stampfer MJ, Willett WC. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142:1009–18.
Karimi E, Haghighatdoost F, Mohammadifard N, Najafi F, Farshidi H, Kazemi T, Solati K, Shahdadian F, Arab A, Sarrafzadegan N, Mansourian M. The influential role of parents’ socioeconomic status and diet quality on their children’s dietary behavior: results from the LIPOKAP study among the Iranian population. BMC Pediatr. 2023;23:188.
Dobiasova M. AIP–atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek. 2006;52:64–71.
Toprak K, Kaplangöray M, Karataş M, Dursun A, Arğa Y, Tascanov MB, Biçer A, Demirbağ R. Atherogenic combined index: validation of a coronary artery disease predictive biomarker. Arch Med Res. 2024;55:103065.
Efrida E, Rofinda ZD, Lipoeto NI, Bakma I. The correlation of adiponectin, high-sensitivity C-reactive protein, and adiponectin/crp ratio to Castelli risk Index-II in cardiovascular disease associated with vitamin-D deficiency in laboratory workers at M. Djamil public hospital, West Sumatra. Mediterranean J Nutr Metabolism. 2024;17:357–67.
Peters AL. Clinical relevance of non-HDL cholesterol in patients with diabetes. Clin Diabetes. 2008;26:3–7.
Qiu J, Huang X, Kuang M, Yang R, Li J, Sheng G, Zou Y. Lipoprotein combine index as a better marker for NAFLD identification than traditional lipid parameters. Diabetes Metab Syndr Obes. 2024;17:2583–95.
Hu X, Liu Q, Guo X, Wang W, Yu B, Liang B, Zhou Y, Dong H, Lin J. The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus. Cardiovasc Diabetol. 2022;21:117.
Sastre-Alzamora T, Tárraga López PJ, López-González ÁA, Vallejos D, Paublini H, Ramírez Manent JI. Usefulness of atherogenic indices for predicting high values of avoidable lost life years heart age in 139,634 Spanish workers. Diagnostics. 2024;14:2388.
Beazer J, Freeman D. Estradiol and HDL function in Women– A partnership for life. J Clin Endocrinol Metabolism 2021, 107.
Kodama S, Tanaka S, Saito K, Shu M, Sone Y, Onitake F, Suzuki E, Shimano H, Yamamoto S, Kondo K, et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med. 2007;167:999–1008.
Maeda K, Noguchi Y, Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med. 2003;37:283–90.
Raposeiras-Roubin S, Rosselló X, Oliva B, Fernández-Friera L, Mendiguren José M, Andrés V, Bueno H, Sanz J, de Martínez V, Abu-Assi E, et al. Triglycerides and residual atherosclerotic risk. JACC. 2021;77:3031–41.
Brown JD, Buscemi J, Milsom V, Malcolm R, O’Neil PM. Effects on cardiovascular risk factors of weight losses limited to 5–10. Transl Behav Med. 2016;6:339–46.
Organization WH. WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke. World Health Organization; 2023.
Bhardwaj S, Bhattacharjee J, Bhatnagar M, Tyagi S, Delhi N. Atherogenic index of plasma, Castelli risk index and atherogenic coefficient-new parameters in assessing cardiovascular risk. Int J Pharm Biol Sci. 2013;3:359–64.
Assempoor R, Daneshvar MS, Taghvaei A, Abroy AS, Azimi A, Nelson JR, Hosseini K. Atherogenic index of plasma and coronary artery disease: a systematic review and meta-analysis of observational studies. Cardiovasc Diabetol. 2025;24:35.
Raaj I, Thalamati M, Gowda V, Rao A. The role of the atherogenic index of plasma and the Castelli risk index I and II in cardiovascular disease. Cureus 2024, 16.
Detection, NCEPEPo. Adults tohbci: third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). The Program; 2002.
Hermans MP, Sacks FM, Ahn SA, Rousseau MF. Non-HDL-cholesterol as valid surrogate to Apolipoprotein B 100 measurement in diabetes: discriminant ratio and unbiased equivalence. Cardiovasc Diabetol. 2011;10:1–7.
Chen H-C, Lee W-C, Fang H-Y, Fang C-Y, Chen C-J, Yang C-H, Wu C-J. Impact of high triglyceride/high-density lipoprotein cholesterol ratio (insulin resistance) in ST-segment elevation myocardial infarction. Medicine. 2020;99:e22848.
Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, Stein JH. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J. 2011;161:145–51.
van der Plas A, Antunes M, Pouly S, de La Bourdonnaye G, Hankins M, Heremans A. Meta-analysis of the effects of smoking and smoking cessation on triglyceride levels. Toxicol Rep. 2023;10:367–75.
Colsoul ML, Goderniaux N, Onorati S, Dupuis S, Jamart J, Vanpee D, Berlin I, Galanti L. Changes in biomarkers of endothelial function, oxidative stress, inflammation and lipids after smoking cessation: a cohort study. Eur J Clin Invest. 2023;53:e13996.
Mladenovic SP. The buffering role of physical activity in the impact of sedentary behavior on lipid metabolism. Stud Sports Sci Phys Educ. 2024;2:25–33.
Wang Y, Xu D. Effects of aerobic exercise on lipids and lipoproteins. Lipids Health Dis. 2017;16:132.
Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55:31–55.
Mirashrafi S, Kafeshani M, Hassanzadeh A, Entezari MH. Is any association between alternate healthy eating index (AHEI) with lipid profile and liver enzymes? A cross-sectional study. J Diabetes Metabolic Disorders. 2021;20:1537–44.
Fung TT, McCullough ML, Newby P, Manson JE, Meigs JB, Rifai N, Willett WC, Hu FB. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2005;82:163–73.
Sotos-Prieto M, Bhupathiraju S, Falcon L, Gao X, Tucker K, Mattei J. Association between a healthy lifestyle score and inflammatory markers among Puerto Rican adults. Nutr Metabolism Cardiovasc Dis. 2016;26:178–84.
Zeinalabedini M, Nasli-Esfahani E, Esmaillzadeh A, Azadbakht L. How is healthy eating index-2015 related to risk factors for cardiovascular disease in patients with type 2 diabetes. Front Nutr. 2023;10:1201010.
Ranjit PM, Pothineni RB, Guntuku G. Estimation of lipid profile and assessment of cardiovascular risk in smokers by using new atherogenic indices. Asian J Pharm Clin Res. 2015;8:247–50.
Agbecha A, Ameh AE. Atherogenic indices and smoking habits in cigarette smokers. Environ Disease. 2018;3:38–44.
Devantier-Du Plessis C, Saric N, Devantier-Du Plessis B, Zaciragic A. Assessment of correlation between lipid ratios and body mass index in patients with type 2 diabetes mellitus in sarajevo, Bosnia and Herzegovina. Endocr Regul. 2024;58:187–94.
Kattula D, Nimmanapalli HD. Association between anthropometric indices, lipid accumulation product and atherogenic indices in adolescents. Int J. 2021;4:519.
Edwards MK, Blaha MJ, Loprinzi PD. Influence of sedentary behavior, physical activity, and cardiorespiratory fitness on the atherogenic index of plasma. J Clin Lipidol. 2017;11:119–25.
Venojärvi M, Korkmaz A, Wasenius N, Manderoos S, Heinonen OJ, Lindholm H, Aunola S, Eriksson JG, Atalay M. 12 weeks’ aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation. Food Chem Toxicol. 2013;61:127–35.
Ezeukwu AO, Agwubike EO, Uadia PO. Differential effects of continuous and interval exercise training on the atherogenic index of plasma in the non-obese young male. Acta Cardiol Sinica. 2015;31:337.
Sotos-Prieto M, Bhupathiraju SN, Falcón LM, Gao X, Tucker KL, Mattei J. A healthy lifestyle score is associated with cardiometabolic and neuroendocrine risk factors among Puerto Rican adults. J Nutr. 2015;145:1531–40.
Malekmohammad K, Bezsonov EE, Rafieian-Kopaei M. Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms. Front Cardiovasc Med. 2021;8:707529.
Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the look AHEAD trial. Arch Intern Med. 2010;170:1566–75.
Dudum R, Juraschek SP, Appel LJ. Dose-dependent effects of lifestyle interventions on blood lipid levels: results from the PREMIER trial. Patient Educ Couns. 2019;102:1882–91.
Khalafi M, Sakhaei MH, Kazeminasab F, Rosenkranz SK, Symonds ME. Exercise training, dietary intervention, or combined interventions and their effects on lipid profiles in adults with overweight and obesity: A systematic review and meta-analysis of randomized clinical trials. Nutr Metabolism Cardiovasc Dis. 2023;33:1662–83.
Xu L, Ding K-w, Yang G-d, Han X-x, Cong X, Wang R-h, Liu X-r, Li N, Xu C-p. Association Between Life’s Essential 8 and Atherogenic Index of Plasma in Adults: Insights from NHANES 2007–2018. 2024.
Jahromi MK, Daftari G, Farhadnejad H, Tehrani AN, Teymoori F, Salehi-Sahlabadi A, Mirmiran P. The association of healthy lifestyle score and risk of non-alcoholic fatty liver disease. BMC Public Health. 2023;23:973.
Chang Y, Li Y, Guo X, Dai D, Sun Y. The association of ideal cardiovascular health and atherogenic index of plasma in rural population: a cross-sectional study from Northeast China. Int J Environ Res Public Health. 2016;13:1027.
Dong T, Zhou Q, Lin W, Wang C, Sun M, Li Y, Liu X, Lin G, Liu H, Zhang C. Association of healthy lifestyle score with control of hypertension among treated and untreated hypertensive patients: a large cross-sectional study. PeerJ. 2024;12:e17203.
Khera AV, Emdin CA, Drake I, Natarajan P, Bick AG, Cook NR, Chasman DI, Baber U, Mehran R, Rader DJ. Genetic risk, adherence to a healthy lifestyle, and coronary disease. N Engl J Med. 2016;375:2349–58.
Mirmiran P, Farhadnejad H, Teymoori F, Parastouei K, Azizi F. The higher adherence to healthy lifestyle factors is associated with a decreased risk of metabolic syndrome in Iranian adults. Nutr Bull. 2022;47:57–67.
Zhu Y, Yang H, Liang S, Zhang H, Mo Y, Rao S, Zhang Y, Zhang Z, Wang W, Yang W. Higher adherence to healthy lifestyle score is associated with lower odds of non-alcoholic fatty liver disease. Nutrients. 2022;14:4462.
Patel YR, Gadiraju TV, Gaziano JM, Djoussé L. Adherence to healthy lifestyle factors and risk of death in men with diabetes mellitus: the physicians’ health study. Clin Nutr. 2018;37:139–43.
Sun C, Li K, Xu H, Wang X, Qin P, Wang S, Liang B, Xu L. Association of healthy lifestyle score with all-cause mortality and life expectancy: a city-wide prospective cohort study of cancer survivors. BMC Med. 2021;19:1–11.
Petermann-Rocha F, Diaz-Toro F, Troncoso-Pantoja C, Martínez-Sanguinetti MA, Leiva-Ordoñez AM, Nazar G, Concha-Cisternas Y, Martínez XD, Lanuza F, Carrasco-Marín F. Association between a lifestyle score and all-cause mortality: a prospective analysis of the Chilean National health survey 2009–2010. Public Health Nutr. 2024;27:e9.
Zhao H-Q, Lv J-L, Gao Y-Z, Hu B, Du Z-D, Wang Y, Wang M-L, Hou M-D, Li F, Xing X. Association between inflammatory score, healthy lifestyle, and cardiovascular disease: a National cohort study. Front Nutr. 2025;12:1534458.
Wang B, Mei Z, Li Y, Dai H, Meng X, An G. Association between nontraditional lipid parameters and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. 2024.
Qin Z, Zhou K, Li Y-p, Wang J-l, Cheng W-j, Hu C-p, Shi C, He H, Zhou Y. -j: remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study. Cardiovasc Diabetol. 2019;18:1–9.
Trialists CT. Efficacy and safety of more intensive Lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010;376:1670–81.
Rabiee Rad M, Ghasempour Dabaghi G, Darouei B, Amani-Beni R. The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: A systematic review and meta-analysis. Cardiovasc Diabetol. 2024;23:119.
Åberg F, Byrne CD, Pirola CJ, Männistö V, Sookoian S. Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease. J Hepatol. 2023;78:191–206.